Stock Fundamentals

Company Information

Company Name
IQVIA Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
ISIN: US46266C1053
CIK: 0001478242
CUSIP: 46266C105
Currency: USD
Full Time Employees: 93,000
Phone: 919 998 2000
Fiscal Year End: December
IPO Date: May 09, 2013
Description:

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Address:

2400 Ellis Road, Durham, NC, United States, 27703

Directors & Officers

Name Title Year Born
Mr. Ari Bousbib CEO & Chairman 1961
Mr. Eric M. Sherbet J.D. Executive VP, General Counsel & Secretary 1964
Mr. W. Richard Staub III President of Research & Development Solutions 1963
Mr. Alistair Grenfell President of Commercial Solutions 1974
Mr. Michael J. Fedock MBA Executive VP & Chief Financial Officer 1976
Mr. James G. Berkshire Executive Vice President of Global Infrastructure & Operations 1974
Ms. Keriann Cherofsky Senior VP, Corporate Controller & Chief Accounting Officer 1985
Dr. Jeffrey A. Spaeder M.D. Chief Medical & Scientific Officer NA
Kerri Joseph Senior VP of Investor Relations & Treasurer NA
Mr. Duane Sachs Senior Vice President of Corporate Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 16, 2026 Kevin Hern N/A Sale N/A $164.90 N/A
Feb 24, 2026 Ro Khanna N/A Sale N/A $164.74 N/A
Jan 29, 2026 Ro Khanna N/A Sale N/A $235.26 N/A
Dec 29, 2025 Markwayne Mullin N/A Purchase N/A $227.08 N/A
Oct 29, 2025 Eric Sherbet N/A Sale 4.00K $219.70 $878.80K
Oct 02, 2025 John Boozman N/A Sale N/A $204.25 N/A
Sep 29, 2025 Ro Khanna N/A Purchase N/A $181.00 N/A
Jul 23, 2025 Eric Sherbet N/A Sale 5.80K $190.05 $1.10M
Jul 23, 2025 Keriann Cherofsky N/A Sale 549.00 $191.53 $105.15K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 19.65M Dec 31, 2025 11.77% $0.06 0.82%
BlackRock Inc 15.03M Mar 31, 2026 9.00% $0.04 6.13%
Harris Associates L.P. 12.18M Mar 31, 2026 7.30% $2.77 7.63%
Vanguard Capital Management, LLC 11.03M Mar 31, 2026 6.61% $0.05 0.00%
Vanguard Portfolio Management, LLC 7.58M Mar 31, 2026 4.54% $0.07 0.00%
State Street Corp 7.48M Mar 31, 2026 4.48% $0.04 0.40%
JPMorgan Chase & Co 5.41M Mar 31, 2026 3.24% $0.06 42.32%
Artisan Partners Limited Partnership 5.06M Mar 31, 2026 3.03% $1.38 50.05%
Geode Capital Management, LLC 4.46M Mar 31, 2026 2.67% $0.05 2.01%
Boston Partners Global Investors, Inc 4.24M Mar 31, 2026 2.54% $0.76 3.71%
Amvescap Plc. 3.26M Mar 31, 2026 1.95% $0.09 31.47%
AllianceBernstein L.P. 2.88M Mar 31, 2026 1.72% $0.21 -12.87%
Morgan Stanley - Brokerage Accounts 2.61M Mar 31, 2026 1.56% $0.03 1.24%
NORGES BANK 2.21M Dec 31, 2025 1.32% $0.05 28.73%
Canada Pension Plan Investment Board 2.00M Mar 31, 2026 1.20% $0.22 17.36%
Longview Partners (Guernsey) Limited 1.90M Mar 31, 2026 1.14% $4.58 -14.54%
Lazard Asset Management LLC 1.86M Mar 31, 2026 1.11% $0.52 -2.01%
FMR Inc 1.85M Mar 31, 2026 1.11% $0.02 -46.81%
Northern Trust Corp 1.73M Mar 31, 2026 1.04% $0.04 -0.25%
Cantillon Capital Management LLC 1.71M Mar 31, 2026 1.03% $1.94 -11.86%

Shares Statistics

Shares Outstanding: 166.90M
Shares Float: 158.55M
% Insiders: 107.90%
% Institutions: 10,370.70%
Short % Float: 3.40%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 5.40M 3.24% ▲ 0.24% Apr 30, 2026
2 Vanguard 500 Index Investor 4.40M 2.63% ▲ 1.82% Apr 30, 2026
3 Vanguard Mid Cap Index Institutional 3.67M 2.20% ▲ 0.25% Apr 30, 2026
4 Oakmark Investor 2.68M 1.61% ▼ 0.96% Mar 31, 2026
5 Oakmark Select Investor 2.35M 1.41% ▲ 11.39% Mar 31, 2026
6 iShares Core S&P 500 ETF 2.23M 1.34% ▲ 0.31% May 29, 2026
7 Fidelity 500 Index 2.17M 1.30% ▲ 0.35% Apr 30, 2026
8 State Street® SPDR® S&P 500® ETF 2.06M 1.23% ▲ 0.11% May 31, 2026
9 Vanguard Windsor II Inv 1.81M 1.08% ▲ 5.99% Mar 31, 2026
10 Vanguard Value Index Inv 1.57M 0.94% ▲ 0.29% Apr 30, 2026

Valuation Metrics

Enterprise Value: $44.25B
Trailing P/E: 22.51
Forward P/E: 14.18

Financial Highlights

Market Cap: $30.29B
EBITDA: $3.00B
P/E Ratio: $22.51
PEG Ratio: $0.73
Book Value: $37.27
Earnings/Share: $8.06
Profit Margin: 8.33%
Operating Margin: 13.61%
ROA (TTM): 5.13%
ROE (TTM): 22.49%
Revenue (TTM): $16.63B
Revenue/Share (TTM): $97.79
Earnings Growth (YOY): 15.00%
Revenue Growth (YOY): 8.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.75x 2.42x 0.78x 3.14x 4.54x
2024-12-31 0.84x 2.30x 0.77x 3.29x 4.05x
2023-12-31 0.86x 2.24x 0.77x 2.94x 4.20x
2022-12-31 0.89x 2.21x 0.77x 4.32x 4.38x
2021-12-31 0.91x 2.01x 0.76x 3.71x 4.38x
2020-12-31 1.12x 2.09x 0.74x 1.76x 6.04x
2019-12-31 1.05x 1.94x 0.73x 1.74x 5.82x
2018-12-31 1.10x 1.64x 0.69x 1.79x 5.85x
2017-12-31 1.22x 1.26x 0.63x 2.08x 6.19x
2016-12-31 1.23x 0.83x 0.58x 4.46x 8.48x
2015-12-31 1.51x -7.35x 1.09x 6.35x 3.21x
2014-12-31 1.46x -3.26x 1.21x 5.87x 3.17x
2013-12-31 1.31x -3.07x 1.22x 3.74x 3.69x
2012-12-31 1.15x -1.78x 1.54x 2.95x 4.84x
2011-12-31 1.15x -2.03x 1.42x 3.17x 5.11x
2010-12-31 N/A N/A N/A 2.79x 0.00x
2009-12-31 N/A N/A N/A N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IQV.US!